DRUGMAKER Merck & Co has announced the adoption of a 'responsible' pricing policy and will cut the prices of certain products, while committing to increasing the average price of its drugs by no more than the annual inflation rate.
Zepatier treatment for Hepatitis C will drop by 60%, and other prices by 10%, the company explained.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jul 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jul 18
